NCCN Guidelines Insights: Soft Tissue Sarcoma, Version 1.2021.


Journal

Journal of the National Comprehensive Cancer Network : JNCCN
ISSN: 1540-1413
Titre abrégé: J Natl Compr Canc Netw
Pays: United States
ID NLM: 101162515

Informations de publication

Date de publication:
02 12 2020
Historique:
entrez: 7 12 2020
pubmed: 8 12 2020
medline: 4 11 2021
Statut: epublish

Résumé

The NCCN Guidelines for Soft Tissue Sarcoma provide recommendations for the diagnosis, evaluation, treatment, and follow-up for patients with soft tissue sarcomas. These NCCN Guidelines Insights summarize the panel discussion behind recent important updates to the guidelines, including the development of a separate and distinct guideline for gastrointestinal stromal tumors (GISTs); reconception of the management of desmoid tumors; inclusion of further recommendations for the diagnosis and management of extremity/body wall, head/neck sarcomas, and retroperitoneal sarcomas; modification and addition of systemic therapy regimens for sarcoma subtypes; and revision of the principles of radiation therapy for soft tissue sarcomas.

Identifiants

pubmed: 33285515
doi: 10.6004/jnccn.2020.0058
pii: jnccnGLINS1812
doi:
pii:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1604-1612

Auteurs

Margaret von Mehren (M)

1Fox Chase Cancer Center.

John M Kane (JM)

2Roswell Park Comprehensive Cancer Center.

Marilyn M Bui (MM)

3Moffitt Cancer Center.

Edwin Choy (E)

4Massachusetts General Hospital Cancer Center.

Mary Connelly (M)

5The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute.

Sarah Dry (S)

6UCLA Jonsson Comprehensive Cancer Center.

Kristen N Ganjoo (KN)

7Stanford Cancer Institute.

Suzanne George (S)

8Dana-Farber/Brigham and Women's Cancer Center.

Ricardo J Gonzalez (RJ)

3Moffitt Cancer Center.

Martin J Heslin (MJ)

9O'Neal Comprehensive Cancer Center at UAB.

Jade Homsi (J)

10UT Southwestern Simmons Comprehensive Cancer Center.

Vicki Keedy (V)

11Vanderbilt-Ingram Cancer Center.

Ciara M Kelly (CM)

12Memorial Sloan Kettering Cancer Center.

Edward Kim (E)

13Fred Hutchinson Cancer Research Center/Seattle Cancer Care Alliance.

David Liebner (D)

5The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute.

Martin McCarter (M)

14University of Colorado Cancer Center.

Sean V McGarry (SV)

15Fred & Pamela Buffett Cancer Center.

Christian Meyer (C)

16The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins.

Alberto S Pappo (AS)

17St. Jude Children's Research Hospital/The University of Tennessee Health Science Center.

Amanda M Parkes (AM)

18University of Wisconsin Carbone Cancer Center.

I Benjamin Paz (IB)

19City of Hope National Medical Center.

Ivy A Petersen (IA)

20Mayo Clinic Cancer Center.

Matthew Poppe (M)

21Huntsman Cancer Institute at the University of Utah.

Richard F Riedel (RF)

22Duke Cancer Institute.

Brian Rubin (B)

23Case Comprehensive Cancer Center/University Hospitals Seidman Cancer Center and Cleveland Clinic Taussig Cancer Institute.

Scott Schuetze (S)

24University of Michigan Rogel Cancer Center.

Jacob Shabason (J)

25Abramson Cancer Center at the University of Pennsylvania.

Jason K Sicklick (JK)

26UC San Diego Moores Cancer Center.

Matthew B Spraker (MB)

27Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine.

Melissa Zimel (M)

28UCSF Helen Diller Family Comprehensive Cancer Center; and.

Mary Anne Bergman (MA)

29National Comprehensive Cancer Network.

Giby V George (GV)

29National Comprehensive Cancer Network.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH